About CANTABIO PHARMACEUTICALS INC
Sector
Industry
CEO
Gergely Tóth
Website
Headquarters
Palo Alto
Founded
2009
ISIN
US13808X2036
FIGI
BBG00329G3X1
Cantabio Pharmaceuticals, Inc. is a preclinical stage biotechnology company, which engages in the commercialization of novel therapies and the intellectual property generated from the research and development activities for Parkinson's, Alzheimer's diseases, and any other related diseases. It focuses on identification and development of small molecule pharmacological chaperones targeting proteins that misfold and aggregated in vivo vivo levels of proteins which display loss of function during disease conditions. The company was founded by Gergely Toth on February 6, 2012 and is headquartered in Palo Alto, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CTBO is 1.01 USD — it has decreased by 95.96% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CANTABIO PHARMACEUTICALS INC stocks are traded under the ticker CTBO.
Yes, you can track CANTABIO PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, CTBO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CANTABIO PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.